Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results

LONDON and SALT LAKE CITY, March 30, 2023 -- Renalytix plc , an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive... | March 30, 2023

Related Keywords

Illinois ,United States ,Ireland ,London ,City Of ,United Kingdom ,Utah ,Florida ,Salt Lake City ,Texas ,New York ,Petersburg ,Sankt Peterburg ,Russia ,American ,Americans ,Peter Denardo ,Gary Clarence Shalin Bhamra ,James Mccullough ,Paul Mcmanus Alice Woodings ,Renalytix Ai Inc ,Exchange Commission On ,Investec Bank ,Joslin Diabetes Center Inc ,American Society Of Nephrology Kidney Week ,Company Kidneyintel ,Astrazeneca ,European Union ,American Association Of Nurse Practitioners Annual Meeting ,World Obesity Federation ,Pnational Kidney Foundation Spring Clinical Meeting ,Community Health ,Master Care Coordination Services Agreement ,Veterans Administration ,Services Revenue ,Bonds ,Nasdaq ,Drug Administration ,Company On ,Kantaro Biosciences ,Joslin Diabetes Technology ,Public Company Accounting Oversight Board ,Renalytix Ai Limited ,Care Coordination Services ,National Government Services ,Many Of The Company ,Company See ,Exchange Commission ,Revenue Service ,Icahn School Of Medicine At Mount Sinai ,Davita Inc ,Uva Health System ,Bio Techne Corporation ,Mount Sinai Health System ,American Diabetes Association ,Astrazeneca The Company ,Advisory Services Agreement ,Journal Of Primary Care Community Health On ,Company Care Coordination Services ,Va Medical Centers ,Centers For Medicare Medicaid Services ,Astrazeneca Pharmaceuticals Lp ,Diagnostics Holding Plc ,Horizon Europe Grant ,Primary Care ,American Society ,Nephrology Kidney Week ,Scientific Session ,American Association ,Nurse Practitioners Annual Meeting ,Wake Forest ,Mount Sinai ,Call Details ,Nominated Adviser ,Joint Broker ,Nicholas Moore ,Nick Moore ,Breakthrough Designation ,Private Securities Litigation Reform Act ,Financial Results ,Six Months ,Annual Report ,Blue Cross Shield ,Medicare Advantage ,Medicaid Services ,Primary Care Community Health ,American Journal ,Managed Care ,Horizon Europe ,Mount Sinai Health ,New York City ,American Depositary ,Value Adjustments ,Value Adjustment ,Currency Gain ,Financial Condition ,Securities Act ,Sarbanes Oxley Act ,Astrazeneca Pharmaceuticals ,Pharmaceutical Services Revenue ,Going Concern ,Accounting Standards Codification ,Accounting Standards Updates ,Financial Accounting Standards Board ,Fair Value Option Subsections ,Financial Instruments ,Icahn School ,American Depository Shares ,Income Taxes ,Jumpstart Our Business Startups Act ,Own Equity ,Convertible Instruments ,Convertible Bonds ,Conversion Price ,Convertible Bond Investor ,Recovered Patients ,Internal Revenue Service ,Clinical Trial Agreement ,Joslin Diabetes Center ,Holding Plc ,Joslin Agreement ,Share Option Plan ,Vesting Commencement ,Months Ended December ,Accounting Bulletin ,Share Purchase Plan ,Stock Compensation ,Black Scholes ,Kantaro Operating Agreement ,Advisory Agreement ,Renalytix Plc Stock Exchange ,News ,Information ,Press Release ,End ,Salt ,Lake ,Arch ,023 ,Renalytix ,Lc ,N ,Rtificial ,Itro ,Iagnostics ,Ocused ,Optimizing ,Linical ,Management ,F ,Kidney ,Disease ,O Rnlx Us75973t1016 ,